Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD. | Clin Transl Med | 2020 | 32997416 | PubTator, text mining | PubMed |
| Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer. | Cell Commun Signal | 2020 | 32948192 | PubTator, text mining | PubMed |
| SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression. | Oncol Rep | 2020 | 32945483 | PubTator, text mining | PubMed |
| Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells. | Cell Rep | 2020 | 32937131 | PubTator, text mining | PubMed |
| Trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells. | Viruses | 2020 | 32932986 | PubTator, text mining | PubMed |
| A Novel Mechanism for NF-κB-activation via IκB-aggregation: Implications for Hepatic Mallory-Denk-Body Induced Inflammation. | Mol Cell Proteomics | 2020 | 32912968 | PubTator, text mining | PubMed |
| Small ubiquitin-like modifier 2 (SUMO2) is critical for memory processes in mice. | FASEB J | 2020 | 32910521 | PubTator, text mining | PubMed |
| CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination. | Elife | 2020 | 32902378 | PubTator, text mining | PubMed |
| TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks. | Proc Natl Acad Sci U S A | 2020 | 32900933 | PubTator, text mining | PubMed |
| Histone chaperone FACT represses retrotransposon MERVL and MERVL-derived cryptic promoters. | Nucleic Acids Res | 2020 | 32894293 | PubTator, text mining | PubMed |
| Guanosine modulates SUMO2/3-ylation in neurons and astrocytes via adenosine receptors. | Purinergic Signal | 2020 | 32892251 | PubTator, text mining | PubMed |
| A protein interaction map identifies existing drugs targeting SARS-CoV-2. | BMC Pharmacol Toxicol | 2020 | 32883368 | PubTator, text mining | PubMed |
| STING cyclic dinucleotide sensing originated in bacteria. | Nature | 2020 | 32877915 | PubTator, text mining | PubMed |
| PICH regulates the abundance and localization of SUMOylated proteins on mitotic chromosomes. | Mol Biol Cell | 2020 | 32877270 | PubTator, text mining | PubMed |
| Fatty Acid Synthase: An Emerging Target in Cancer. | Molecules | 2020 | 32872164 | PubTator, text mining | PubMed |
| Stability of Begomoviral pathogenicity determinant βC1 is modulated by mutually antagonistic SUMOylation and SIM interactions. | BMC Biol | 2020 | 32867776 | PubTator, text mining | PubMed |
| Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma. | J Clin Lab Anal | 2020 | 32860274 | PubTator, text mining | PubMed |
| Expression of Concern: Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. | Biosci Rep | 2020 | 32857153 | PubTator, text mining | PubMed |
| The immunology of COVID-19: is immune modulation an option for treatment? | Lancet Rheumatol | 2020 | 32835246 | PubTator, text mining | PubMed |
| TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy. | Sci Adv | 2020 | 32832608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=38